Cesca Therapeutics Announces First Quarter 2019 Financial Results And Provides Corporate Update

Wednesday, May 15, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Conference Call to be Held Today at 1:30 p.m. PDT/4:30 p.m. EDT

Cesca Therapeutics Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Three Months Ended

March 31,

2019

2018

Cash flows from operating activities:

         Net cash used in operating activities

$(2,443,000)

$(2,063,000)

Cash flows from investing activities:

     Capital expenditures

(38,000)

(290,000)

Cash flows from financing activities:

     Payments on capital lease obligations

--

--

     Proceeds from issuance of common stock, net

--

1,213,000

     Proceeds from long-term debt-related party

1,513,000

500,000

    Proceeds from note payable

800,000

--

    Proceeds from exercise of pre-funded warrants

5,000

--

        Net cash provided by financing activities

2,318,000

1,713,000

Effects of foreign currency rate changes on cash and cash equivalents

--

(1,000)

Net decrease in cash, cash equivalents and restricted cash

(163,000)

(641,000)

Cash, cash equivalents and restricted cash at beginning of period

3,400,000

4,513,000

Cash, cash equivalents and restricted cash at end of period

$3,237,000

$3,872,000



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store